Search Results 2091-2100 of 19174 for Enzyme

1. Study to Evaluate the Safety and Efficacy of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Previously Untreated Adults With TP53 Mutant Acute Myeloid Leukemia - Mayo Clinic

   Individuals appropriate for non-intensive therapy, who have received treatment with strong and/or moderate cytochrome P450 enzyme 3A (CYP3A) inducers within ...

2. Oliceridine (intravenous route) - Side effects & uses - Mayo Clinic

   Poor metabolizers of certain enzymes (eg, CYP2D6)—Use with caution. The effects may be increased because of slower removal of the medicine from the body ...

3. Rifampin and isoniazid (oral route) - Side effects & dosage - Mayo Clinic

   Porphyria (an enzyme problem) or; Seizures or; Vitamin K deficiency—Use with caution. May make these conditions worse. Gout, acute or; Liver disease, acute or ...

4. Gene Editing and Cellular Engineering: David (Chun-Wei) D. Chen - Mayo Clinic Research

   We have developed a high-resolution genetic screening approach called single-cell CRISPR gene tiling, also known as sc-tiling. This method enables the de novo ...

5. Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence - Mayo Clinic

   ... enzyme [ACE] inhibitor plus diuretic, calcium channel blocker plus ACE inhibitor). History of pulmonary embolism, deep vein thrombosis, or prior clinically ...

6. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   History of intolerance to at least one immunosuppressant (including, but not limited to nausea/vomiting, abdominal pain, pancreatitis, liver enzyme ...

7. Publications - Benjamin H. Eidelman, M.D. - Mayo Clinic

   Role of catecholamine degradative enzymes and the adrenergic innervation in determining the cerebrovascular response to infused norepinephrine. Stroke. 1979 ...

8. Publications - Nicholas Y. Tan, M.D., M.S. - Mayo Clinic

   ... Enzyme Inhibitor/Angiotensin Receptor Blocker. Mayo Clin Proc Innov Qual Outcomes. 2021 Apr; 5 (2):286-297 Epub 2021 Feb 15. View PubMed; Breen TJ, Jain CC ...

9. Hyperoxaluria and oxalosis - Doctors and departments - Mayo Clinic

   Evaluation of new treatments for enteric hyperoxaluria, including treatments taken by mouth, also called orally administered, of oxalate-degrading enzymes and ...

10. A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis - Mayo Clinic

    ... enzyme elevation and ECG changes) or uncorrected valvular disease and not primarily due to AL amyloid cardiomyopathy;; Inpatient admission to a hospital for ...